Recurrent Osteosarcoma Recruiting Phase 2 Trials for Fludarabine (DB01073)

Also known as: Osteosarcoma recurrent / Osteogenic sarcoma recurrent

IndicationStatusPhase
DBCOND0028757 (Recurrent Osteosarcoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03449108LN-145 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Osteosarcoma, or Other Bone and Soft Tissue SarcomasTreatment